RADX TECH PROJECT, L3 HEALTHCARE, LLC：育空地区拭子的 RADX 性能评估-猫眼课题宝

RADX TECH PROJECT, L3 HEALTHCARE, LLC：育空地区拭子的 RADX 性能评估

批准号：

10506141

负责人：

CHERMAEN CLINDBERG

金额：

$17.3万

依托单位：

依托单位国家：

美国

项目类别：

财政年份：

2021

资助国家：

美国

项目状态：

已结题

起止时间：

2021-01-12 至 2021-02-28

来源：

https://reporter.nih.gov/project-details/10506141

关键词：

American COVID-19 COVID-19 detection COVID-19 diagnostic COVID-19 testing Centers for Disease Control and Prevention (U.S.)Clinical Contracts Department of Defense Development Device Designs Diagnostic tests Ensure Evaluation Exhalation Funding Goals Healthcare Home Improve Access Laboratories Life Cycle Stages Modification National Institute of Biomedical Imaging and Bioengineering Patients Performance Point of Care Technology Privatization Program Development RADx RADx Tech Readiness Research Saliva Sampling Seasons Sensitivity and Specificity Speed Structure Swab Technology Test Result Testing Time TimeLine United States National Institutes of Health Validation Virus Yukon Territory base commercialization cost design detection limit flu handheld mobile device home test improved innovation meetings novel point of care product development programs scale up technology development user-friendly

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has an open solicitation for proposals to provide up to $500 million across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches. RADx is structured to deliver innovative testing strategies to the public as soon as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文